Back to Search Start Over

[Cystinuria].

Authors :
Prot-Bertoye C
Daudon M
Tostivint I
Dousseaux MP
Defazio J
Traxer O
Knebelmann B
Courbebaisse M
Source :
Nephrologie & therapeutique [Nephrol Ther] 2021 Apr; Vol. 17S, pp. S100-S107.
Publication Year :
2021

Abstract

Cystinuria is the most common monogenic nephrolithiasis disorder. Because of its poor solubility at a typical urine pH of less than 7, cystine excretion results in recurrent urinary cystine stone formation. A high prevalence of high blood pressure and of chronic kidney disease has been reported in these patients. Alkaline hyperdiuresis remains the cornerstone of the preventive medical treatment. To reach a urine pH between 7.5 and 8 and a urine specific gravity less than or equal to 1.005 should be the goal of medical treatment. D-penicillamine and tiopronin, two cysteine-binding thiol agents, should be considered as second line treatments with frequent adverse events that should be closely monitored.<br /> (Copyright © 2020 Société francophone de néphrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.)

Details

Language :
French
ISSN :
1872-9177
Volume :
17S
Database :
MEDLINE
Journal :
Nephrologie & therapeutique
Publication Type :
Academic Journal
Accession number :
33910689
Full Text :
https://doi.org/10.1016/j.nephro.2020.03.001